SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001193125-17-176606
Filing Date
2017-05-19
Accepted
2017-05-19 16:10:56
Documents
8
Period of Report
2017-05-15
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 5.03: Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 FORM 8-K d590602d8k.htm 8-K 23891
2 EX-3.1 d590602dex31.htm EX-3.1 14845
3 EX-3.2 d590602dex32.htm EX-3.2 15330
4 EX-3.3 d590602dex33.htm EX-3.3 13373
5 EX-10.1 d590602dex101.htm EX-10.1 190543
6 GRAPHIC g590602dsp007.jpg GRAPHIC 24111
7 GRAPHIC g590602dsp7.jpg GRAPHIC 6581
8 GRAPHIC g590602dsp7a.jpg GRAPHIC 5912
  Complete submission text file 0001193125-17-176606.txt   310087
Mailing Address 4960 PEACHTREE INDUSTRIAL BOULEVARD SUITE 240 NORCROSS GA 30071
Business Address 4960 PEACHTREE INDUSTRIAL BOULEVARD SUITE 240 NORCROSS GA 30071 678-620-3186
GALECTIN THERAPEUTICS INC (Filer) CIK: 0001133416 (see all company filings)

IRS No.: 043562325 | State of Incorp.: NV | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-31791 | Film No.: 17857917
SIC: 2834 Pharmaceutical Preparations